Quintiles has targeted Africa as the next non-traditional area to develop new medicines and the opening of its office in Ghana, which is now fully operational, is a major step in this process, Gillian Corken, head of Quintiles in Africa, told Outsourcing-Pharma.
OmniComm has acquired Logos Technologies’ electronic data capture (EDC) assets, the second deal of this type it has made in the past 6 weeks, further strengthening its presence in the market.
US software company Velos hopes its new “software as a service” (SaaS) internet offering will attract CROs and Pharma firms seeking low-cost trial management solutions.
UK software group Cisiv has unveiled a web-based EDC platform, Baseline Plus, which is specifically tailored to meet the demands of post market trials.
Germany’s XClinical says 2008 was a successful year with a 20 per cent hike in revenues for its electronic data capture (EDC) and clinical data/trial management (CDM/CTM) software.
Pfizer has become the first drugmaker to win accreditation for protecting the human rights of subjects enrolled into early-stage clinical trials under a scheme operated by the Association for the Accreditation of Human Research Protection Programs (AAHRPP).
ReSearch Pharmaceutical Services has expanded its activities into the Asian market via the purchase of Chinese contract research organisation (CRO) Paramax International.
eClinical company etrials saw losses increase in the fourth quarter of 2008, but pointed to a healthy increase in orders as evidence of the underlying strength of the business.
Contract research organisation Bio-Imaging Technologies has decided to sell off its CapMed subsidiary in order to focus its efforts on its core business, providing imaging series to clinical investigators.
There is no formal requirement to inform clinical trial participants of the results of the study, a situation which can leave them “confused, frustrated and, in some cases, lacking information that may be important to their health,” according to a report...
India’s Jubilant Organosys has bolstered its mid-range contract research portfolio by buying Canadian electronic data capture (EDC) specialist TrialStat ClinicalAnalytics.
Shifting clinical trial operations from Western markets to India can reap substantial benefits for sponsors in saved costs and time, according to KPMG’s just-published report India Pharma Inc.
Recent developments in the clinical research sector include an acquisition by Canada’s Algorithme, a Dutch CRO looking to push into the North American market, and a £20m boost for UK clinical research.
Contrary to fears, the European Union’s Clinical Trials Directive has not had an inhibitory effect on the number of studies carried out by publicly-funded researchers, at least in Denmark.
Contract research organisation MDS Pharma Services has launched a
new version of its ClinQuick electronic data capture (EDC) system
designed to help in the design and management of Phase I clinical
studies.
Quintiles Transnational has heralded the results of an
independently conducted study of clinical investigator sites across
Europe that saw the firm rate the highest overall in terms of
satisfaction.
At present India appears to be beating China in the race for Asia's
top clinical spot, according to new figures published by india´s
Planning Commission.
Synchron Research has revealed it is close to opening up new
operations in Vietnam and Hong Kong - within the next six months -
and has just bought a new business in France and strengthened its
ties with Parexel.
Outsourcing-Pharma.com compiles the news that has featured in the
clinical contract community of late, involving PRA International
and Premier Research.
A Polish and a Czech firm have merged together in a bid to
strengthen their position in the Central and Eastern Europe's
(CEE's) budding clinical research scene.
Japan's Eisai has inked a deal with Accenture to have it provide it
with global clinical data management services from India, and
becomes the first big Japanese pharma firm to take such a step.
Dublin-based contract research organisation (CRO) Icon Clinical
Research has forayed further into Eastern Europe with the opening
of three new offices there.
This week two sets of contract research organisations (CROs) have
announced plans to link arms in order to spread their reach further
into this increasingly globalised marketplace.
The US Food and Drug Administration (FDA) has slammed
Sanofi-Aventis over its failure to act on known instances of fraud
during clinical trials of its antibiotic Ketek (telithromycin) -
accusations that the firm continues to deny.
Despite the hype, countries in emerging markets are still very much
trailing behind the US in the number of Food and Drug
Administration (FDA)-approved studies being conducted, particularly
the Asia-pacific, a survey by Parexel reveals.
Contract research organisation (CRO) Chiltern has announced it is
expanding its services with a new solution aimed at helping clients
boost their clinical research staff recruitment process - an
increasingly difficult task due to...
Octagon has bought an electronic data capture (EDC) company and is
now claiming to be the first company to address the process problem
in clinical R&D by offering "an end-to-end solution that
crosses traditional functional...
Two companies have gone a step further to capture a bigger chunk of
the budding eClinical market by offering a new integrated solution
for pharma companies who continue to move away from paper toward
electronic reporting in clinical...
A new clinical research tool is now available, offering
investigators the ability to integrate clinical data from a number
of different sources across the clinical development spectrum.
Before deciding what part of a clinical trial to outsource, one of
the most important things a sponsor should do is define its core
competencies and then outsource accordingly.
UK-based Synexus Clinical Research is continuing its global
movements with the latest acquisition of South African outfit
Clinical Research Centers (CRC).
A new firm called Clinical Conduct Associates has been launched in
Ireland in the hope of attracting new clinical research business to
this "underutilised region" from pharmaceutical companies
throughout Europe.
As India's clinical trials industry continues to explode, lack of
experienced clinical research employees in the region is slowing
down progress and leading to fierce poaching between firms.
Data management solutions provider Phase Forward used the recent
Drug Information Association (DIA) to unveil a new programme
tailored to help clinical research organizations (CROs) of all
sizes optimise their eClinical profitability.
eClinical software and services firm etrials has launched the
latest version of its eDiary technology, which the company claims
will lead to cost savings and increased efficiency in the clinical
trial process.
Chiltern is expanding its clinical trial services business in
India, and in doing so will be the first company to provide
specialised staff recruitment services for the Indian clinical
research industry.
According to a new report, technical advances in the R&D
environment have promoted the uptake of biochips in clinical
research applications. However, the report identified the high
prices as a prime area of concern.
UK-based Synexus Clinical Research has formed the first
patient-recruitment site management organisation (SMO) in India to
cash in on India's burgeoning clinical research market.
India's clinical research industry is currently valued at $100
million (€83 million) and is almost doubling each year, reflecting
the shifting focus of the pharmaceutical outsourcing industry to
Asia.
Penn Pharmaceutical Services has reported strong sales figures for
the fifth consecutive year, with a key driver of recent growth
being attributed to a boom in contract manufacturing as well as
small-scale commercial batches.
